Jury deliberations resume in Vegas hepatitis trial Nevada Appeal Mon, 03 May 2010 10:06 AM PDT LAS VEGAS - Jury deliberations resume for a second day in the civil trial of drug companies accused of providing the anesthetic used by Las Vegas endoscopy clinics at the heart of a hepatitis C outbreak. The Clark County District Court jury returns to work Monday after deliberating Friday following more than two weeks of testimony in a lawsuit by Las Vegas residents 61-year-old Henry Chanin ... | Brewers Uecker has successful heart surgery Wausau Daily Herald Mon, 03 May 2010 09:54 AM PDT MILWAUKEE Milwaukee Brewers radio announcer Bob Uecker had successful heart surgery Friday, a six-hour procedure that will keep him away from his beloved team for up to three months. | Rogers lives life on her terms The Daily Iberian Mon, 03 May 2010 09:46 AM PDT Congestive heart failure led doctors to believe Emily Rogers had only one year left to live, but five years later, she continues to defy medical expertise. | 5-year-old heart-surgery patient recovering Calaveras Enterprise Mon, 03 May 2010 09:39 AM PDT Family and community members signed a T-shirt for Nicholas at a blood drive held in advance of his surgery. Enterprise photo by Krissi Khokhobashvili On a recent morning, 5-year-old Nicholas Somraty sat in a recliner, calmly playing a handheld videogame in the living room of his Valley Springs home while four of his siblings ran around the living room and his baby sister took a nap. | (AFX UK Focus) 2010-05-03 17:27 UPDATE 1-US reviews diabetes,heart risk with prostate drugs Interactive Investor Mon, 03 May 2010 09:33 AM PDT WASHINGTON, May 3 (Reuters) - The U.S. Food and Drug Administration is examining whether certain hormone treatments for men with prostate cancer pose greater risk for diabetes or heart trouble. The FDA is looking at data from published studies to determine the risks with commonly used Gonadotropin-Releasing Hormone (GnRH) agonist drugs, the agency said on Monday. | FDA issues advisory on prostate cancer drugs News-Medical-Net Mon, 03 May 2010 09:27 AM PDT Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration. | U.S. reviews diabetes,heart risk with prostate drugs Reuters Mon, 03 May 2010 09:26 AM PDT WASHINGTON (Reuters) - The U.S. Food and Drug Administration is examining whether certain hormone treatments for men with prostate cancer pose greater risk for diabetes or heart trouble. | | |
|
No comments:
Post a Comment